Sign in

    Matthew Rothway

    Research Analyst at UBS

    Matthew Rothway is an Analyst at UBS Securities LLC specializing in equity research, covering companies such as RH Petrogas, Heineken Malaysia, and China Yuchai across the energy, consumer, and industrial sectors. In his current role, Rothway has contributed to investment reports that have outperformed consensus expectations, highlighted by coverage on stocks with strong free cash flow yields and notable earnings beats. He began his professional investment career at TIAA-CREF Investment Management before joining UBS in 2024, building a track record of sound financial analysis and sector expertise. Rothway maintains relevant financial industry credentials including securities registrations, underscoring his commitment to rigorous professional standards.

    Matthew Rothway's questions to US Foods Holding (USFD) leadership

    Matthew Rothway's questions to US Foods Holding (USFD) leadership • Q1 2025

    Question

    Matthew Rothway, on for Mark Carden, asked for details on trends in the chain and healthcare segments, noting the weakness in chains and acceleration in healthcare. He also inquired about the company's sales force hiring plans for the year.

    Answer

    CFO Dirk Locascio explained that the decline in the chain segment was in line with broader industry traffic and that the company's focus remains on the more profitable independent, healthcare, and hospitality segments. He highlighted the continued strong, differentiated growth in healthcare. CEO Dave Flitman added that the company's hiring plan remains a target of mid-single-digit growth for the sales force, consistent with prior years.

    Ask Fintool Equity Research AI

    Matthew Rothway's questions to Grocery Outlet Holding (GO) leadership

    Matthew Rothway's questions to Grocery Outlet Holding (GO) leadership • Q1 2025

    Question

    Matthew Rothway, on for Mark Carden, asked for an explanation of the Q1 gross margin outperformance and why that strength is not fully reflected in the full-year outlook.

    Answer

    CFO Chris Miller attributed the Q1 beat primarily to lower inventory shrinkage resulting from improved systems and processes, which he noted is a sustainable gain. While there is potential for further margin upside from assortment mix (opportunistic and private label) in the back half of the year, he stated it was too early to quantify the full impact and build it into guidance.

    Ask Fintool Equity Research AI

    Matthew Rothway's questions to UNITED NATURAL FOODS (UNFI) leadership

    Matthew Rothway's questions to UNITED NATURAL FOODS (UNFI) leadership • Q1 2025

    Question

    Matthew Rothway from UBS asked for an update on the progress toward achieving the previously announced $150 million cost efficiency goal.

    Answer

    President & CFO Matteo Tarditi clarified that the $150 million is a target for the three-year strategic plan, not a single year. He cited the 65-basis-point reduction in OpEx as a percentage of sales in Q1 as a key proof point, driven by Lean management, improved throughput, and a more decentralized, leaner organization.

    Ask Fintool Equity Research AI

    Matthew Rothway's questions to Ollie's Bargain Outlet Holdings (OLLI) leadership

    Matthew Rothway's questions to Ollie's Bargain Outlet Holdings (OLLI) leadership • Q1 2025

    Question

    Matthew Rothway of UBS Group AG, on behalf of Mark Carden, asked what was driving lower supply chain costs and whether the full-year expectation for flat supply chain costs remains.

    Answer

    CFO Robert Helm explained that while tariffs are a slight headwind within supply chain costs, this is being offset by favorable ocean contract negotiations, positive domestic transportation rates, and record efficiency at the distribution centers. These factors contribute to the overall cost management.

    Ask Fintool Equity Research AI